Literature DB >> 44377

Characterization of the two major species of slow reacting substance from rat basophilic leukemia cells as glutathionyl thioethers of eicosatetraenoic acids oxygenated at the 5 position. Evidence that peroxy groups are present and important for spasmogenic activity.

C W Parker, M M Huber, M K Hoffman, S F Falkenhein.   

Abstract

The most prominent slow reacting substance from rat basophilic leukemia cells (type I) was characterized by radiochemical, chemical and physical methods and shown to contain a C20 unsaturated fatty acid oxygenated at the 5 position and a sulfur containing side chain in thioether linkage at the 6 position. Its spasmogenic action on guinea pig ileal muscle was largely inactivated under reducing conditions which suggested that a peroxy group was present and important for contractile activity. This was supported by ferrous thiocyanate analysis. The peroxy group is almost certainly at the 5 position, probably in the form of a peroxy ester or hydroperoxide. Based on amino acid hydrolysis (0.85 moles of glycine and 0.30 moles of glutamic acid per mole SRS), the sulfur containing side chain is apparently a mixture of glutathione and cysteinyl-glycine, but by chromatography the side chain is predominantly glutathione and the low yield of glutamic acid may be due to complexing of its alpha COOH group in a peroxy ester linkage. The fatty acid moiety has 3 conjugated double bonds, probably at the 7,8, 9,10 and 11,12 positions. Type II SRS, the second major species, differs in that the sulfur containing side chain is linked at the 12 or 13 position and is almost certainly glutathione and in the failure of alkaline borohydride to produce inactivation. These observations strongly implicate the lipoxygenase pathway in slow reacting substance biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 44377     DOI: 10.1016/0090-6980(79)90088-1

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  10 in total

Review 1.  Metabolites of arachidonic acid.

Authors:  W F Stenson; C W Parker
Journal:  Clin Rev Allergy       Date:  1983-09

2.  Mast cells and basophils: effector cells of inflammatory disorders in the lung.

Authors:  H H Newball; L Lichtenstein
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

Review 3.  LTC4 synthase. Enzymology, biochemistry, and molecular characterization.

Authors:  J F Penrose
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

4.  Release of a slow-reacting substance from rabbit platelets.

Authors:  J M Mencia-Huerta; L Hadji; J Benveniste
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

5.  Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis.

Authors:  L B Klickstein; C Shapleigh; E J Goetzl
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

6.  SRS-A mediated bronchospasm by pharmacologic modification of lung anaphylaxis in vivo.

Authors:  D M Ritchie; J N Sierchio; R J Capetola; M E Rosenthale
Journal:  Agents Actions       Date:  1981-07

7.  Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airways in vitro.

Authors:  Z Marom; J H Shelhamer; M Kaliner
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

8.  Relationship of biosynthesis of slow reacting substance to intracellular glutathione concentrations.

Authors:  C W Parker; C M Fischman; H J Wedner
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

9.  Prostaglandins, ductus arteriosus, pulmonary circulation: current concepts and clinical potential.

Authors:  F Coceani; P M Olley; J E Lock
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

10.  Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B.

Authors:  E J Goetzl; W C Pickett
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.